Dow Inc is not a good buy right now for a Beginner investor focused on long-term investing, despite some improving analyst sentiment and a few supportive catalysts. The stock has short-term technical weakness, mixed fundamentals, and recent hedge fund selling. If the investor is impatient and unwilling to wait for a better entry, this is not the best time to initiate a new position.
Price is 37.39, slightly above the prior close but the broader move is weak with the stock down 3.06% during the regular session. Technically, MACD histogram is negative and expanding, which signals weakening momentum. RSI_6 at 31.47 is near oversold but not a strong reversal signal yet. The moving averages are bullish in structure (SMA_5 > SMA_20 > SMA_200), so the longer trend is still intact, but price is sitting very close to support at 37.425 and below the pivot of 39.188, which means the stock is still in a fragile spot.

Analysts have mostly turned more constructive: RBC, JPMorgan, BMO, Morgan Stanley, Citi, and Alembic all raised targets or upgraded views, reflecting better earnings expectations and improved polyethylene pricing. The Q1 earnings beat and robust Q2 outlook are meaningful positives. Middle East supply disruptions may support petrochemical pricing and margins. Congress trading data is mildly supportive, with 1 recent purchase and no sales, showing at least some institutional-political confidence. Insider activity is neutral, not negative.
Hedge funds are actively selling, with selling up sharply over the last quarter, which is a major caution flag. Q1 revenue fell 6.11% year over year and gross margin also declined, showing the business is still under pressure. Net income remains negative at -$535 million. News included mostly unrelated items, so there is no strong fresh company-specific news catalyst beyond commodity pricing. The stock also lost 3.06% in the regular session and is trading below the pivot level, indicating near-term weakness.
In Q1 2026, Dow reported revenue of $9.794 billion, down 6.11% year over year, which shows softer top-line demand. Net income improved in the sense that losses narrowed to -$535 million, up 72.58% year over year, and EPS improved to -$0.74, but the company is still unprofitable. Gross margin fell to 6.06%, down 8.73% year over year, so profitability remains tight. Overall, the latest quarter was better on earnings trajectory but still weak on revenue and margins.
Analyst sentiment has improved notably over the last several weeks, with multiple target increases from Deutsche Bank, RBC, JPMorgan, BMO, Morgan Stanley, Alembic, and Citi. Targets now cluster mostly in the low- to mid-$40s, with some bullish calls as high as $50-$51, while current price is around $37.4. The Wall Street pros view is mixed: the bulls see upside from better polyethylene pricing, supply disruptions, and earnings recovery; the cautious side includes UBS’s Neutral view and Deutsche Bank’s Hold, suggesting near-term rangebound trading. Overall, analysts are leaning more positive, but not unanimously bullish.